We would like to invite you to attend a live webinar about screening with the Biodesy Delta. To register for this event, please click here or for more information:
2016 Prism Award recognizes product innovation and potential to tackle grand challenges of our time
Company signs 20th pharmaceutical service contract; funds to be used to commercialize the Biodesy™ Delta System
Biodesy™ Delta System and performance data to be presented at upcoming Society for Laboratory Automation & Screening Meeting
Biodesy, Inc. announced it entered into a research collaboration agreement with Amgen Inc. to support Amgen’s neuroscience drug discovery programs.
Frost & Sullivan proudly recognizes Biodesy as the recipient of the 2014 Technology Innovation Leadership Award for Protein Analysis
Series A investors include 5AM Ventures, Pfizer Venture Investments and Roche Venture Fund
Biodesy announced it has received a supplement to its Phase II Small Business Innovation Research (SBIR) Award from the National Science Foundation (NSF)